Zimbabwe has rejected a significant US health deal worth 367 million US dollars (£272m) spanning five years over the United States' insistence on confidential data.
This move was revealed after a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesman has since stated that the US was requesting health data for research and commercial gain but was not willing to guarantee the benefits from any future vaccines.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged continued dialogue to find a agreement agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Background
This rejection follows a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and responsibility.
According to reports, Sixteen African countries have to date signed similar agreements, representing over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that shared data," his statement read.
"Put simply, our country would supply the raw materials for medical research with no certainty that the end products would be accessible to our population if a future health crisis emerge."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining systems previously established via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This framework is intended to ensure that when a country provides its data, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further discussions with our American counterparts on how future co-operation might be designed in a manner that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but suggested that negotiations need to persist given that a large portion of the nation's HIV programmes relied on foreign aid.
"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group added.
The halted deal highlights the continuing debate between receiving much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.